Case Report: Teprotumumab treatment in an HIV-infected patient with refractory thyroid eye disease: clinical and quantitative MRI evidence
BackgroundPeople living with human immunodeficiency virus (HIV) may develop Graves’ disease as a delayed autoimmune manifestation of immune reconstitution inflammatory syndrome following antiretroviral therapy. Thyroid eye disease (TED) is uncommon in …